Squarepoint Ops LLC

Position in OVID — Ovid Therapeutics Inc.

CIK 1642575 NEW YORK, NY

Position in OVID

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$50,940

-$388,555 QoQ

Shares Held

18,937

-90.4% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#94

of 130 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. OVID ranks #240 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	198,567	$123,814,467
2	BBIO	BridgeBio Pharma, Inc.	1,191,732	$88,760,199
3	ALNY	Alnylam Pharmaceuticals, Inc.	233,999	$70,440,718
4	INSM	INSMED Inc	616,464	$65,727,391
5	ARGX	Argenx SE	58,400	$54,181,768
6	RYTM	Rhythm Pharmaceuticals, Inc.	422,921	$46,956,918
7	APGE	Apogee Therapeutics, Inc.	290,713	$38,586,336
8	AXSM	Axsome Therapeutics, Inc.	154,605	$37,842,665

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$50,940	18,937	-90.4%	Shares	Defined	2026-08-14
2026-03-31	$439,495	197,971	+407.2%	Shares	Defined	2026-05-15
2025-12-31	$63,625	39,034	-66.0%	Shares	Defined	2026-02-13
2025-09-30	$149,399	114,923	-48.0%	Shares	Defined	2025-11-14
2025-06-30	$72,971	221,126	-16.7%	Shares	Defined	2025-08-27
2025-03-31	$82,833	265,491	+288.5%	Shares	Defined	2025-08-27
2024-03-31	$208,446	68,343	+500.5%	Shares	Defined	2024-05-15
2023-12-31	$36,646	11,381	+1.0%	Shares	Defined	2024-02-14
2023-03-31	$29,079	11,271	+6.9%	Shares	Defined	2023-05-15
2022-06-30	$22,667	10,543	-72.1%	Shares	Defined	2022-08-15
2021-06-30	$147,786	37,797	-46.8%	Shares	Defined	2021-08-16
2020-12-31	$163,979	70,987	-49.6%	Shares	Defined	2021-02-16
2020-09-30	$807,721	140,718	+1118.0%	Shares	Defined	2020-11-16
2020-03-31	$34,427	11,553	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.